AL Amyloidosis, A Curable Disease? - Wikidata - awgldk - TriplyDB

AL Amyloidosis, A Curable Disease?

AL Amyloidosis, A Curable Disease?

http://www.wikidata.org/entity/Q58162286

about

AL Amyloidosis, A Curable Disease?

http://www.wikidata.org/entity/Q58162286

description

im September 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 September 2002

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2002

@uk

name

AL Amyloidosis, A Curable Disease?

@en

AL Amyloidosis, A Curable Disease?

@nl

type

label

AL Amyloidosis, A Curable Disease?

@en

AL Amyloidosis, A Curable Disease?

@nl

prefLabel

AL Amyloidosis, A Curable Disease?

@en

AL Amyloidosis, A Curable Disease?

@nl

P1433

Q58162286-9346F8D0-E06B-4072-A523-0E0F42AA473A

P1476

Q58162286-107C5B75-92AD-41CD-BA91-5177F842D832

P2093

Q58162286-3A9A56FD-BCCE-4B7C-99A9-369FB580434D

P2860

Q58162286-029A8DBC-85D9-4E2B-82F7-14B1DD05A1EB

Q58162286-78170CBD-4CB5-4FCA-A81F-75EEDAF75AAF

Q58162286-78A7F85B-8CE0-4224-90D7-AA63D8E6BAC6

Q58162286-8725B345-1B23-4ABE-A099-84395D67CBCB

Q58162286-B1124D98-8467-4F94-A178-047C227AC022

Q58162286-D74D0DA9-625C-4A84-AB65-1698E38DEDA5

Q58162286-F42236D1-6D6C-4DAC-BC36-33C1C1A870F9

Q58162286-FAC32C80-ED2B-431E-998C-3C00AE8AC8AB

P304

Q58162286-077E6E56-70D2-4B71-894A-DCB18293C228

P31

Q58162286-60dbbbc5-2d28-4ada-b108-d0b74bc99984

Q58162286-AA9DE20D-D4A4-47EF-B247-DE1ABD518257

P356

Q58162286-2519F00B-854F-42D0-9856-2C385A7CA0CF

P433

Q58162286-CE1CFC97-8D59-4C25-9F60-1E2C2BB93C66

P478

Q58162286-6B60C560-6230-46C8-A0F6-F78B1B844498

P577

Q58162286-D8177EB6-92AD-4253-9E14-952278CE5555

P698

Q58162286-7B0C2CA0-3150-4F80-B675-62BA019F246C

P356

13506120209114825

P1433

P1476

AL amyloidosis, a curable disease?

@en

P2093

David C Seldin

http://www.w3.org/2001/XMLSchema#string

P2860

Translocation T(4;14)(p16.3;q32) is a recurrent genetic lesion in primary amyloidosis

Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis.

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.

Autologous stem cell transplantation for primary systemic amyloidosis.

Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses.

High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant.

Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.

Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

P304

203-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13506120209114825

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12408686

http://www.w3.org/2001/XMLSchema#string